Iovance Biotherapeutics, Inc. (IOVA) has a market capitalization of $1.21B and trades at $3.64. The 52-week range is 1.64-5.63.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.3, Earnings Per Share (EPS) of $-1.09, annual revenue of $263.5M.
The stock has a beta of 0.76, operates in the Healthcare sector.
